Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabozantinib for Plexiform Neurofibromas in NF1
NCT02101736Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2014
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabozantinib in plexiform neurofibroma (PN), sponsored by University of Alabama at Birmingham. Started Jun 2014; status: completed.
02
Drugs
cabozantinib
03
Conditions
plexiform neurofibroma (PN)
Beyond the preview
Go deeper on NCT02101736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02101736.